Diabetes

Health plans and pharmacy benefits managers are expected to scrutinize the FDA approval to ensure that only those patients who truly need the drug get it.Drugmakers say discounts will cause the price to fall below the $14,600 annual wholesale price listed.

The Sanofi and Regeneron therapy, to be marketed as Praluent, was among the most-anticipated FDA approvals of the year. Late-day reports put pricing at $40 a day wholesale, well above estimates, although insurers will seek discounts.

The authors undertook a literature search on treatment intensification in diabetes care to identify relevant research that has been published since 2000.

The proposal marks the latest attempt to give consumers more information about the foods they consume.

CMS' shift to value-based payments has also shifted diabetes care models from cost-centered systems to cost-savings centers, according to Robert A. Gabbay, MD, PhD, chief medical officer and senior vice president of Joslin Diabetes Center.

The study has policy implications since Americans 65 and older are eligible for Medicare, and trustees reported this week that the hospital fund will only be solvent until 2030.

Kerri Sparling, writer/editor at patient diabetes blog Six Until Me, knows from experience the importance of having a community support system when dealing with a chronic illness like diabetes.

The findings have policy importance in the developing world, where low birth weight is often followed by rapid transition to Western lifestyles.

Data from mHealth can inform, assess, anticipate, and aid in interventions while monitoring and coordinating patient health status and care.

The results will not wipe out a recent $2.37 billion settlement reached in about 9000 bladder cancer claims involving the drug.

Researchers at UCLA have discovered that inhibiting SGLT2 in pancreatic and prostate adenocarcinomas can reduce cancer cell survival.

Managing diabetes is about more than just blood-sugar elevation; discussions about management should go beyond medication adherence to include how the disease affects a patient's life, explains Andrew Pumerantz, DO, FACP.

In a pattern repeated among those who gained insurance on the Marketplace exchanges, it's clear the uninsured had more pent-up medical needs than policymakers realized.

There are a number of things that Paul Ciechanowski, MD, MPH, associate professor at the University of Washington, believes play a role in medication nonadherence among patients with diabetes, such as patient engagement in their care.

Highlights from the American Diabetes Association's 75th Scientific Sessions, which took place on June 5-9, 2015, in Boston, are available in a newsletter published by The American Journal of Managed Care.

Scientists at the University of Leeds have developed a device that avoids the constant finger pricks in hyperglycemic patients.

Individuals living with a combination of diabetes and cardiovascular disease are more likely to have a shorter life expectancy, researchers from the University of Cambridge found.

This study examines the association between plan-level measures of health outcomes and medication adherence to assess the viability of adherence as a measure of plan performance.

A new study published in Neurology, has shown that long-term inflammation in older patients with diabetes can also hasten their cognitive decline.

Cardiovascular disease may be the leading cause of death in the United States, but half of those deaths can be prevented, according to researchers from Emory's Rollins School of Public Health.

Scientists at the Imperial College London have identified a genetic link to obesity and diabetes in an extremely obese woman and her family members.

The JAMA authors recommend that HHS and the US Department of Agriculture pay attention to DGAC's recommendations on fat intake, which do not include an upper limit on total fat consumption.

When evaluating the cost-effectiveness of 4 different interventions to prevent or reduce childhood obesity, researchers found that the benefit of these interventions surpassed the current clinical interventions to treat obesity.

Home healthcare transition from hospitals for diabetic Medicare home healthcare beneficiaries can be improved by identifying risk factors for 30-day readmissions due to ambulatory care—sensitive conditions.

Quality of care and relative resource use for patients with diabetes are not necessarily positively related. Further, the relationship varies by year, plan type, and region.